Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Doerte R. Fricke
Observed name:
Doerte Raphaela Fricke
Institution:
Louisiana State University Health Sciences Center New Orleans
Observed institution:
Louisiana State University Health Sciences Center New Orleans
ORCID:
0000-0001-6171-331X
Observed ORCID:
0000-0001-6171-331X
OpenAlex ID:
A5065105077
Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer
2021
·
Gang Liu
, Hyejin Kim
, et al.
·
European Journal of Medicinal Chemistry
·
20
PDF
Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia
2021
·
Yifeng Dai
, Zhiheng Cheng
, et al.
·
Journal of Cellular and Molecular Medicine
·
9
PDF
Protein S in preventing thrombosis
2019
·
Doerte R. Fricke
, Sabyasachi Chatterjee
, et al.
·
Aging
·
4
PDF
Abstract 426: Development of oridonin-based proteolysis-targeting chimera (PROTAC) degraders as effective breast cancer therapeutics
2022
·
Ruixia Ma
, Pingyuan Wang
, et al.
·
Cancer Research
·
1
Abstract 3940: Novel Bax activators for targeted breast cancer therapy
2022
·
Doerte Raphaela Fricke
, Gang Liu
, et al.
·
Cancer Research
Abstract 424: Development of HJC0152-based proteolysis-targeting chimera degraders for breast cancer therapy
2022
·
Junhai Xu
, Jimin Xu
, et al.
·
Cancer Research
Abstract 1238: Treating estrogen receptor (ER)-negative and triple-negative breast cancer by targeting STAT3 signaling with putative STAT3 inhibitors
2021
·
Hyejin Kim
, Doerte R. Fricke
, et al.
·
Cancer Research
Abstract 1239: Putative Bax activators GL0385 and GL0388 for targeted breast cancer therapy
2021
·
Doerte R. Fricke
, Hyejin Kim
, et al.
·
Cancer Research
Laminin G Domains of Protein S Bind and Inhibit Fixa
2019
·
Sabyasachi Chatterjee
, Amber Sylvain
, et al.
·
Blood
Show more works
View as search
Works count:
9
Citation count:
34
H-index:
3
I10-index:
1
Year
Topic
Type